Two multicenter trials drew different conclusions about the value of conduction system relative to biventricular pacing for ...

The findings suggest that use of the pacing technique during CRT should be reserved for expert operators, at least for now.

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) ...

Multicenter randomized trial (n=200) assigned LBBP versus BiVP for CRT in LBBB with LVEF ≤35%, using time to death or HF hospitalization as primary endpoint. Event rates favored LBBP, reducing death ...

A 173-patient randomized trial in HFrEF (LVEF ≤35%) with LBBB (QRS ≥130 ms) showed CSP was inferior to BiVP for a hierarchical 12‑month composite endpoint. Worse outcomes with CSP were reflected by an ...

The study showed that LBBP significantly reduced the risk of death or hospitalization for heart failure compared with BiVP in ...

Medtronic plc (NYSE:MDT) is one of the 7 Most Undervalued Blue Chip Stocks to Invest In. On March 23, 2026, Medtronic plc ...

Sports cardiology has emerged as a distinct subspecialty at the intersection of preventive cardiology and athlete care. While ...

Recent developments of interest in cardiovascular medicine ...

This March, the American Red Cross urges donors to help the national blood supply recover following a severe shortage and ...

UK Finance shared that Britain's banking industry is undergoing a quiet but significant transformation, with momentum in customer pricing strategies.